Ameritas Investment Partners’s Verrica Pharmaceuticals VRCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-172
| Closed | -$762 | – | 3354 |
|
|
2025
Q1 | $762 | Hold |
172
| – | – | ﹤0.01% | 3112 |
|
|
2024
Q4 | $1.21K | Hold |
172
| – | – | ﹤0.01% | 3115 |
|
|
2024
Q3 | $2.5K | Hold |
172
| – | – | ﹤0.01% | 3091 |
|
|
2024
Q2 | $12.6K | Hold |
172
| – | – | ﹤0.01% | 2839 |
|
|
2024
Q1 | $10.2K | Hold |
172
| – | – | ﹤0.01% | 2809 |
|
|
2023
Q4 | $12.6K | Hold |
172
| – | – | ﹤0.01% | 2770 |
|
|
2023
Q3 | $6.7K | Hold |
172
| – | – | ﹤0.01% | 2934 |
|
|
2023
Q2 | $9.95K | Buy |
+172
| New | +$9.95K | ﹤0.01% | 2912 |
|
|
2022
Q2 | – | Sell |
-108
| Closed | -$9K | – | 3247 |
|
|
2022
Q1 | $9K | Hold |
108
| – | – | ﹤0.01% | 2841 |
|
|
2021
Q4 | $10K | Hold |
108
| – | – | ﹤0.01% | 2907 |
|
|
2021
Q3 | $14K | Hold |
108
| – | – | ﹤0.01% | 2852 |
|
|
2021
Q2 | $12K | Hold |
108
| – | – | ﹤0.01% | 2904 |
|
|
2021
Q1 | $16K | Hold |
108
| – | – | ﹤0.01% | 2661 |
|
|
2020
Q4 | $12K | Hold |
108
| – | – | ﹤0.01% | 2720 |
|
|
2020
Q3 | $8K | Hold |
108
| – | – | ﹤0.01% | 2829 |
|
|
2020
Q2 | $12K | Hold |
108
| – | – | ﹤0.01% | 2640 |
|
|
2020
Q1 | $12K | Hold |
108
| – | – | ﹤0.01% | 2459 |
|
|
2019
Q4 | $17K | Hold |
108
| – | – | ﹤0.01% | 2494 |
|
|
2019
Q3 | $16K | Buy |
108
+78
| +260% | +$11.6K | ﹤0.01% | 2520 |
|
|
2019
Q2 | $3K | Hold |
30
| – | – | ﹤0.01% | 2998 |
|
|
2019
Q1 | $3K | Hold |
30
| – | – | ﹤0.01% | 2922 |
|
|
2018
Q4 | $2K | Hold |
30
| – | – | ﹤0.01% | 2961 |
|
|
2018
Q3 | $5K | Buy |
+30
| New | +$5K | ﹤0.01% | 2953 |
|